Clinical trial for Tauopathies
Official title Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
ClinicalTrials.gov ID: NCT06932809
What this study is testing
What is 18F-JSS20-183A PET?
an investigational PET imaging radiotracer being studied to detect abnormal 4‑repeat tau protein in tauopathies such as PSP, CBS, FTLD, Parkinson's and Alzheimer's disease.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to learn where the tracer goes, how it is broken down and cleared, and how well it reaches brain areas with abnormal tau protein.
- Who it's for
- Adults who have a tauopathy such as progressive supranuclear palsy, corticobasal syndrome, genetic frontotemporal dementia, Parkinson’s disease, Alzheimer’s disease, or who are healthy volunteers.
- What's involved
- Participants receive a single injection of the radioactive tracer and then undergo PET imaging of the brain, plus blood and urine samples to track metabolism and excretion.
- Time commitment
- The study involves one visit lasting a few hours for the injection, scans, and sample collection.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 85
You may be able to join if
- Patients in all cohorts will be male or female adults from 40 to 85 years of age.
- Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this...
You likely can't join if
- Females who are pregnant or breast feeding will be excluded, a urine pregnancy test will be performed in women of child-bearing potential prior to...
- Forms of parkinsonism other than PSP-RS, and PD as defined above
- History of significant or ongoing alcohol abuse or substance abuse or dependence based on medical record review or self-reported
- Contraindications or inability to tolerate imaging, arterial line or IV placement or blood draw procedures in the opinion of an investigator or...
- Contraindication to MRI, such as non-compatible implanted medical device
- Any current medical condition, illness, or disorder as assessed by medical record review and/or self-reported that is considered by a physician or...
The study team makes the final eligibility decision.
Where it is enrolling
- San Francisco, California, United States
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at San Francisco, California, United States; Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.